CClinicalTrials.gg
CompletedNCT07050147SENNIUpdated Jul 3, 2025

Sonographic Evaluation of Diaphragmatic Function Under Nasal High-flow (NHF) and Non-invasive Ventilation (NIV) in Respiratory Insufficiency

An interventional study of Nasal high flow and NIV in Respiratory Insufficiency, sponsored by Klinikum Emden. Completed at 1 site in Germany. Per ClinicalTrials.gov, last updated 2025-07-03.

Sponsored by Klinikum Emden · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 years 6 months after the study started (first participant enrolled Jul 2019, registered Jan 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Randomized
Sex
All
01

Study summary

The aim of the study is to investigate the influence of respiratory support on diaphragmatic function (O2, NHF, NIV). The effects on the diaphragm, the respiratory values (FEV1, respiratory rate) and the subjective well-being of the patients during the therapy phases will be measured.

The primary objective of the clinical study is to investigate the differences in respiratory support with regard to the change in diaphragmatic kinetics and morphology (Tdi; TEx; Tdi, ee, Tdi, pi, ΔTdi, TFdi) as a function of respiratory rate.

For both ventilation modes, the influence on the respiratory situation, the respiratory muscle pump and adverse events will also be analysed. This is done using defined variables (FEV1, FEV1%VC, respiratory rate, frequency and type of adverse events (AEs), subjective satisfaction with the test product (Borg scale)).

02

Conditions studied

  • Respiratory Insufficiency

Keywords

  • nasal high flow
  • NIV
  • diaphragm
  • sonography
03

In context

Respiratory Insufficiency

1,650 studies on the registry are indexed under Respiratory Insufficiency; 296 are open to participants now.

This study's enrollment of 35 is below the median of 55 across 1,043 interventional studies indexed under Respiratory Insufficiency.

Browse Respiratory Insufficiency studies →

Lead sponsor

Klinikum Emden is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • acute or chronic respiratory insufficiency with and/or hypercapnia,
  • age > 18 years.
  • tolerate respiratory support devices
  • to sign a written declaration of consent

Exclusion criteria

Exclusion Criteria:

  • Presence of respiratory insufficiency requiring intubation,
  • clinical instability,
  • metabolic acidosis or alkalosis,
  • Contraindication for NIV according to the S3 guideline,
  • serious concomitant illnesses,
  • unwillingness to co-operate
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
35 participants (actual)

Study arms

  • Active comparator
    Nasal high flow

    Device: Nasal high flow

  • Active comparator
    NIV

    Device: NIV

Interventions

  • DeviceNasal high flow

    3 sonographic measurements after use of 30 minutes

  • DeviceNIV

    3 sonographic measurements after 30 minutes use

06

What researchers measure

Primary outcomes

  1. Sonographic measurements of diaphragm thickness

    Tdi ee in mm = Diaphragm thickness is determined by measuring the distance between the diaphragmatic pleura and the diaphragm/peritoneum border at maximum expiration

    Time frame: after 30 minutes use

Secondary outcomes

  1. DEx

    Diaphragm excursion during rest

    Time frame: 30 minutes

  2. FEV1

    Forced vital capacity in 1 second as % predicted

    Time frame: 30 min

  3. Tiffeneau - index

    FEV1%FVC in % = definition of obstruction of the airways

    Time frame: 30 min

  4. Respiratory rate

    counts the respiratory cycles in 1 minute

    Time frame: 30 min

  5. Tdi pi

    Diaphragm thickness is determined by measuring the distance between the diaphragmatic pleura and the diaphragm/peritoneum border at maximum inspiration (Tdi, pi) in mm

    Time frame: 30 minutes

  6. TF di

    Thickening Fraction (calculated): TFdi Diaphragm thickening fraction (change in diaphragm thickness during inspiration as a percentage \[calculation from the quotient of ΔTdi and Tdi,ee\])

    Time frame: 30 min

07

Study locations

1 site
  • University of Leipzig
    Leipzig, 04103, Germany
08

References and documents

Individual participant data

Plan to share: Yes — All data upon request

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07050147
Lead sponsor
Klinikum Emden
Collaborators
University of Leipzig
Responsible party
Jens Bräunlich (Clinical director, Head of department, Klinikum Emden) — Principal investigator
First posted
Jul 3, 2025
Start date
Jul 1, 2019
Primary completion
Jan 1, 2025
Completion
Jan 1, 2025
Last update
Jul 3, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion